{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:25:38Z","timestamp":1779128738669,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,20]]},"DOI":"10.7759\/cureus.67260","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T07:28:08Z","timestamp":1724138888000},"source":"Crossref","is-referenced-by-count":3,"title":["Clinical Significance and Potential Function of Complement Factor D in Acute Myeloid Leukemia"],"prefix":"10.7759","author":[{"given":"Taigang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaozhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoyu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Cancer stat facts. leukemia - acute myeloid leukemia (AML). (2019). Accessed: August 14, 2024: https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel RL","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019, 69:7-34. 10.3322\/caac.21551","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.813","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials","volume":"301","author":"Koreth J","year":"2009","unstructured":"Koreth J, Schlenk R, Kopecky KJ, et al.. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA. 2009, 301:2349-61. 10.1001\/jama.2009.813","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis RM","year":"2019","unstructured":"Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019, 36:70-87. 10.1016\/j.blre.2019.04.005","journal-title":"Blood Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1994.1021","article-title":"Structure of human factor D. A complement system protein at 2.0 A resolution","volume":"235","author":"Narayana SV","year":"1994","unstructured":"Narayana SV, Carson M, el-Kabbani O, et al.. Structure of human factor D. A complement system protein at 2.0 A resolution. J Mol Biol. 1994, 235:695-708. 10.1006\/jmbi.1994.1021","journal-title":"J Mol Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2016.06.018","article-title":"Complement factor D homolog involved in the alternative complement pathway of rock bream (Oplegnathus fasciatus): molecular and functional characterization and immune responsive mRNA expression analysis","volume":"55","author":"Godahewa GI","year":"2016","unstructured":"Godahewa GI, Perera NC, Bathige SD, Nam BH, Noh JK, Lee J. Complement factor D homolog involved in the alternative complement pathway of rock bream (Oplegnathus fasciatus): molecular and functional characterization and immune responsive mRNA expression analysis. Fish Shellfish Immunol. 2016, 55:423-33. 10.1016\/j.fsi.2016.06.018","journal-title":"Fish Shellfish Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.712572","article-title":"Complement factor D as a strategic target for regulating the alternative complement pathway","volume":"12","author":"Barratt J","year":"2021","unstructured":"Barratt J, Weitz I. Complement factor D as a strategic target for regulating the alternative complement pathway. Front Immunol. 2021, 12:712572. 10.3389\/fimmu.2021.712572","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","author":"Afshar-Kharghan V","year":"2017","unstructured":"Afshar-Kharghan V. The role of the complement system in cancer. J Clin Invest. 2017, 127:780-9. 10.1172\/JCI90962","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.97","article-title":"Complement in cancer: untangling an intricate relationship","volume":"18","author":"Reis ES","year":"2018","unstructured":"Reis ES, Mastellos DC, Ricklin D, Mantovani A, Lambris JD. Complement in cancer: untangling an intricate relationship. Nat Rev Immunol. 2018, 18:5-18. 10.1038\/nri.2017.97","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-1106-x","article-title":"BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration","volume":"39","author":"Loveridge CJ","year":"2020","unstructured":"Loveridge CJ, Slater S, Campbell KJ, et al.. BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration. Oncogene. 2020, 39:1797-806. 10.1038\/s41388-019-1106-x","journal-title":"Oncogene"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0477-8","article-title":"Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin","volume":"38","author":"Goto H","year":"2019","unstructured":"Goto H, Shimono Y, Funakoshi Y, et al.. Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin. Oncogene. 2019, 38:767-79. 10.1038\/s41388-018-0477-8","journal-title":"Oncogene"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2000092","article-title":"A distinct innate immune signature of early onset colorectal cancer","volume":"5","author":"Gardner IH","year":"2021","unstructured":"Gardner IH, Siddharthan R, Watson K, et al.. A distinct innate immune signature of early onset colorectal cancer. Immunohorizons. 2021, 5:489-99. 10.4049\/immunohorizons.2000092","journal-title":"Immunohorizons"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020305","article-title":"Complement factor D is a novel biomarker and putative therapeutic target in cutaneous squamous cell carcinoma","volume":"14","author":"Rahmati Nezhad P","year":"2022","unstructured":"Rahmati Nezhad P, Riihil\u00e4 P, Knuutila JS, et al.. Complement factor D is a novel biomarker and putative therapeutic target in cutaneous squamous cell carcinoma. Cancers (Basel). 2022, 14:10.3390\/cancers14020305","journal-title":"Cancers (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina J","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, et al.. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012, 483:603-7. 10.1038\/nature11003","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3307","article-title":"The human protein atlas: a spatial map of the human proteome","volume":"27","author":"Thul PJ","year":"2018","unstructured":"Thul PJ, Lindskog C. The human protein atlas: a spatial map of the human proteome. Protein Sci. 2018, 27:233-44. 10.1002\/pro.3307","journal-title":"Protein Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar DS","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, et al.. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022, 25:18-27. 10.1016\/j.neo.2022.01.001","journal-title":"Neoplasia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar DS","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SA, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BV, Varambally S. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017, 19:649-58. 10.1016\/j.neo.2017.05.002","journal-title":"Neoplasia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang Z","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017, 45:W98-W102. 10.1093\/nar\/gkx247","journal-title":"Nucleic Acids Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-023-00742-4","article-title":"Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer","volume":"45","author":"Gy\u0151rffy B","year":"2023","unstructured":"Gy\u0151rffy B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience. 2023, 45:1889-98. 10.1007\/s11357-023-00742-4","journal-title":"Geroscience"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac129","article-title":"CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer","volume":"23","author":"Lin A","year":"2022","unstructured":"Lin A, Qi C, Wei T, et al.. CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer. Brief Bioinform. 2022, 23:10.1093\/bib\/bbac129","journal-title":"Brief Bioinform"},{"key":"ref21","article-title":"Risk factors and primary prevention of acute leukemia","volume":"7","author":"Ilhan G","year":"2006","unstructured":"Ilhan G, Karakus S, Andic N. Risk factors and primary prevention of acute leukemia. Asian Pac J Cancer Prev. 2006, 7:515-17.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-023-10343-7","article-title":"Significance of CD80 as a prognostic and immunotherapeutic biomarker in lung adenocarcinoma","volume":"61","author":"Feng W","year":"2023","unstructured":"Feng W, He Z, Shi L, Zhu Z, Ma H. Significance of CD80 as a prognostic and immunotherapeutic biomarker in lung adenocarcinoma. Biochem Genet. 2023, 61:1937-66. 10.1007\/s10528-023-10343-7","journal-title":"Biochem Genet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-017-0456-2","article-title":"Treatment of relapsed\/refractory acute myeloid leukemia","volume":"18","author":"Bose P","year":"2017","unstructured":"Bose P, Vachhani P, Cortes JE. Treatment of relapsed\/refractory acute myeloid leukemia. Curr Treat Options Oncol. 2017, 18:17. 10.1007\/s11864-017-0456-2","journal-title":"Curr Treat Options Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0210-0","article-title":"Context-dependent roles of complement in cancer","volume":"19","author":"Roumenina LT","year":"2019","unstructured":"Roumenina LT, Daugan MV, Petitprez F, Saut\u00e8s-Fridman C, Fridman WH. Context-dependent roles of complement in cancer. Nat Rev Cancer. 2019, 19:698-715. 10.1038\/s41568-019-0210-0","journal-title":"Nat Rev Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.582955","article-title":"Transcriptome-based co-expression of BRD4 and PD-1\/PD-L1 predicts poor overall survival in patients with acute myeloid leukemia","volume":"11","author":"Chen C","year":"2020","unstructured":"Chen C, Xu L, Gao R, et al.. Transcriptome-based co-expression of BRD4 and PD-1\/PD-L1 predicts poor overall survival in patients with acute myeloid leukemia. Front Pharmacol. 2020, 11:582955. 10.3389\/fphar.2020.582955","journal-title":"Front Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.07.012","article-title":"RUNX1 mutation and elevated FLT3 gene expression cooperates to induce inferior prognosis in cytogenetically normal acute myeloid leukemia patients","volume":"28","author":"Rehman A","year":"2021","unstructured":"Rehman A, Akram AM, Chaudhary A, et al.. RUNX1 mutation and elevated FLT3 gene expression cooperates to induce inferior prognosis in cytogenetically normal acute myeloid leukemia patients. Saudi J Biol Sci. 2021, 28:4845-51. 10.1016\/j.sjbs.2021.07.012","journal-title":"Saudi J Biol Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.19746\/j.cnki.issn.1009-2137.2021.05.007","article-title":"Clinical Characteristics of Acute Myeloid Leukemia Patients with RUNX1 Gene Mutation [Article in Chinese]","volume":"29","author":"Ni ZF","year":"2021","unstructured":"Ni ZF, Ma LJ, Shi LL, Shen PL, Zhao JQ. Clinical Characteristics of Acute Myeloid Leukemia Patients with RUNX1 Gene Mutation [Article in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021, 29:1411-16. 10.19746\/j.cnki.issn.1009-2137.2021.05.007","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.990034","article-title":"Prognostic characteristics of immune subtypes associated with acute myeloid leukemia and their identification in cell subsets based on single-cell sequencing analysis","volume":"10","author":"Lu J","year":"2022","unstructured":"Lu J, Zheng G, Dong A, et al.. Prognostic characteristics of immune subtypes associated with acute myeloid leukemia and their identification in cell subsets based on single-cell sequencing analysis. Front Cell Dev Biol. 2022, 10:990034. 10.3389\/fcell.2022.990034","journal-title":"Front Cell Dev Biol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174216","article-title":"Regulatory effects of IL-1\u03b2 in the interaction of GBM and tumor-associated monocyte through VCAM-1 and ICAM-1","volume":"905","author":"Shen CK","year":"2021","unstructured":"Shen CK, Huang BR, Yeh WL, et al.. Regulatory effects of IL-1\u03b2 in the interaction of GBM and tumor-associated monocyte through VCAM-1 and ICAM-1. Eur J Pharmacol. 2021, 905:174216. 10.1016\/j.ejphar.2021.174216","journal-title":"Eur J Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-013058","article-title":"Monocytes in the tumor microenvironment","volume":"16","author":"Ugel S","year":"2021","unstructured":"Ugel S, Can\u00e8 S, De Sanctis F, Bronte V. Monocytes in the tumor microenvironment. Annu Rev Pathol. 2021, 16:93-122. 10.1146\/annurev-pathmechdis-012418-013058","journal-title":"Annu Rev Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/271166-clinical-significance-and-potential-function-of-complement-factor-d-in-acute-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T07:28:14Z","timestamp":1724138894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/271166-clinical-significance-and-potential-function-of-complement-factor-d-in-acute-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.67260","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,20]]}}}